NICE responds to failure of talks to reach price agreement on Enhertu
Talks with the makers of Enhertu have ended without agreement, meaning guidance that does not recommend Enhertu for advanced breast cancer will remain unchanged.
News, blogs and podcasts
Latest articles
Two technologies recommended for people with chronic tic disorders and Tourette syndrome
Draft guidance issued for consultation recommends two technologies to help people manage their condition.
New study shows NICE Advice support can reduce appraisal timelines by 3 months
Companies who receive scientific advice from our NICE Advice service may experience a faster path to guidance publication, a study has found.
Our updated guideline to improve the diagnosis of endometriosis
The guideline makes new recommendations and updates existing ones on diagnosing and managing a condition that affects approximately 1.5 million women of reproductive age in the UK.
Latest in-depth
A simple guide to how NICE makes its decisions
How we make independent decisions on the cost and clinical effectiveness of medicines and treatments.
Improving care and survival rates for people with spinal cancer
How Clatterbridge Cancer Centre improved early detection rates of metatstatic spinal cord compression, and increased the average survival rates of patients through following our recommendations.
Latest blogs
A safe space for bold ideas – implementing a sandbox approach in health technology assessment
Colleagues in our Science Policy and Research Programme discuss their international research, paving the way for next generation health technology assessment.
Planning for the International Recognition Procedure
5 ways NICE Advice can help you navigate this new opportunity alongside health technology assessment.
Latest podcasts
Make your voice heard on a NICE committee
Learn more about NICE's new guideline on identifying and managing adrenal insufficiency
